The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #2 is about a biotech by the name of Viking Therapeutics (VKTX). The reason why I want to go over this ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

Newswise — JMIR Publications is pleased to announce a new theme issue titled “Machine Learning-Based Predictive Models Using Genomic Data” in JMIR Bioinformatics and Biotechnology. The peer-reviewed ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion Because of these barriers, biotechnology organizations are turning in growing numbers to alternative ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge, so do opportunities in the supply chain.

VERAXA Biotech ( VRXA) said it is implementing FDA-aligned New Approach Methodologies (NAMs) across its preclinical research and development programs to potentially accelerate clinical advancement and ...

In the face of ongoing economic pressure and risk aversion, the evolution of partnering in drug development "is leading to a re-evaluated approach to biotechnology", according to consultants Deloitte.

Avance Clinical, the Australian-headquartered global contract research organization (CRO) specializing in early phase and First-in-Human trials for biotechs across North America, Asia Pacific, China ...